Generic Fentora Doesn't Violate Teva IP, Fed. Circ. Finds
The Federal Circuit on Thursday revived two patents held by a Teva Pharmaceutical Industries Ltd. subsidiary covering the painkiller Fentora, but affirmed a lower court's finding that Actavis Inc.'s bid to...To view the full article, register now.
Already a subscriber? Click here to view full article